J
John G.F. Cleland
Researcher at National Institutes of Health
Publications - 1276
Citations - 125527
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Papers
More filters
Journal ArticleDOI
Elevated Glycated Haemoglobin is a Strong Predictor of Mortality in Patients with Left Ventricular Systolic Dysfunction who are not receiving treatment for Diabetes Mellitus
Kevin Goode,Joseph John,Alan S. Rigby,Eric S Kilpatrick,Steve Atkin,Thanjuvar Bragadeesh,Andrew L. Clark,John G.F. Cleland +7 more
TL;DR: The abrupt increase in mortality with HbA1c may make it a useful risk stratification tool in non-diabetic patients with LVEF ⩽45% which could help improve clinical management.
Journal ArticleDOI
Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe†
Jörg Muntwyler,Alain Cohen-Solal,Nick Freemantle,Joanne Eastaugh,John G.F. Cleland,Ferenc Follath +5 more
TL;DR: To study the role of sex, age and concomitant diseases for prescription of cardiovascular drugs among patients with heart failure cared for in the community.
Journal ArticleDOI
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I)
Ted Feldman,Jan Komtebedde,Daniel Burkhoff,Joseph M. Massaro,Mathew S. Maurer,Martin B. Leon,David M. Kaye,Frank E. Silvestry,John G.F. Cleland,Dalane W. Kitzman,Spencer H. Kubo,Dirk J. van Veldhuisen,Franz X. Kleber,Jean-Noël Trochu,Angelo Auricchio,Finn Gustafsson,Gerd Hasenfuβ,Piotr Ponikowski,Gerasimos Filippatos,Laura Mauri,Sanjiv J. Shah +20 more
TL;DR: The rationale for a therapeutic transcatheter interatrial shunt device in HFpEF is given, and the design of REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I), the first randomized controlled trial of a device-based therapy to reduce left atrial pressure, is described.
Journal ArticleDOI
Management strategies for a better outcome in unstable coronary artery disease
R. W. F. Campbell,Lars Wallentin,Freek W.A. Verheugt,Alexander G.G. Turpie,Attilio Maseri,Werner Klein,John G.F. Cleland,Christoph Bode,Richard C. Becker,Jeffrey L. Anderson,M. E. Bertrand,C. R. Conti +11 more
TL;DR: Clinical stabilization is a term encompassing both unstable angina and non‐Q‐wave (non‐ST‐segment elevation) myocardial infarction; after clinical stabilization, ongoing assessment should include exercise testing for all patients who are able; other imaging techniques should be used for patients unable to exercise.
Journal ArticleDOI
Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs
Praveen Thokala,H Baalbaki,Alan Brennan,Abdullah Pandor,John Stevens,Tim Gomersall,J Wang,Ameet Bakhai,Abdallah Al-Mohammad,John G.F. Cleland,Martin R. Cowie,Ruth Wong +11 more
TL;DR: Cost-effectiveness analyses suggest that TM was an optimal strategy in most scenarios, but there is considerable uncertainty in relation to clear descriptions of the interventions and robust estimation of costs.